Cognitive-Behavioral Therapy for Chronic Insomnia After Breast Cancer Treatment
Completed · Not applicable · Has a placebo group
Conditions studied: Breast Cancer
In brief
The primary goal of the proposed study is to examine a cognitive behavioral intervention for insomnia (CBTI) in women after breast cancer treatment. Chronic Insomnia is a highly prevalent and distressing symptom in cancer patients. CBTI is considered the treatment of choice for chronic primary insomnia. Few studies have been conducted in cancer survivors to evaluate the effect of CBTI on sleep and clinically relevant outcomes.
Key facts
- Study ID
- NCT00672217
- Run by
- University of Colorado, Denver
- People needed
- 64
- Starts
- 2008-07-01
- Expected to finish
- 2013-05-01
- Last updated by the study team
- 2015-05-27
Who can join
Age: 21 and older, up to 65. Sex: female. Healthy volunteers: not accepted.
You may qualify if…
- 21 to 65 years of age inclusive
- 1-36 months after radiation or chemotherapy for non-metastatic breast cancer and on a stable dose of anti-estrogen agent and medications for hot flashes
- Meets diagnostic criteria for chronic, secondary insomnia
- Speak and write English
You may not qualify if…
- Presence of a serious unstable physical illness other than cancer
- Presence of dementia, major depression, psychosis or other serious psychiatric disorder
- Presence of a sleep disorder other than insomnia
- Unstable doses of psychotropic medications (excluding hypnotics), opioids, anit-endocrine medications, or use of high dose steroids
- Current evening/night shift employment
Where it is running
- University of Colorado, College of Nursing — Aurora, Colorado, United States
Full record on ClinicalTrials.gov
Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.